Merck Chairman and CEO Robert Davis joins 'Mad Money' host Jim Cramer to talk quarterly results, what sectors it is seeing strength in, its recent acquisition of Verona Pharma and more. Got a ...

PhRMA CEO Stephen Ubl sits down with CNBC's Annika Kim Constantino to discuss PhRMA's launch of America Cures and the decision to bring in Merck CEO Rob Davis as the next Chair of the PhRMA board. Got ...

Let's get started. Very excited to welcome Merck to our next session, Rob Davis, Chairman and CEO; Dean Li, EVP and President of Merck Research Labs. Welcome, Rob and Dean. Yes. No, happy to do, and ...

Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches and its drug pipeline. Stream NBC 5 for free, 24/7, wherever you are.